BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11229277)

  • 1. Role of DNA probes in characterization of pathogenic and non-pathogenic E. histolytica.
    Agarwal SK; Guleria P; Gupta S; Goel V; Bhattacharya S
    J Assoc Physicians India; 1998 Aug; 46(8):701-3. PubMed ID: 11229277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of polymerase chain reaction and nonradioactive DNA probes to diagnose Entamoeba histolytica in clinical samples.
    Romero JL; Descoteaux S; Reed S; Orozco E; Santos J; Samuelson J
    Arch Med Res; 1992; 23(2):277-9. PubMed ID: 1340314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic differentiation with restriction patterns between pathogenic and non-pathogenic monoxenic Entamoeba histolytica].
    Crisóstomo Vázquez P; Jiménez Cardoso E
    Rev Invest Clin; 2000; 52(3):255-60. PubMed ID: 10953608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenic Entamoeba histolytica--a rare incidence in persons microscopically positive for cysts in faeces].
    Nohýnková E; Pysová I; Tůmová P; Tolarová V
    Cas Lek Cesk; 2007; 146(2):132-6. PubMed ID: 17373108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of the polymerase chain reaction to the epidemiological study of amoebiasis].
    Guo ZZ; Zhu H; An YJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):303-5. PubMed ID: 8706101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the prevalence of Entamoeba histolytica and E. dispar in the pernambuco state of northeastern Brazil by a polymerase chain reaction.
    Pinheiro SM; Carneiro RM; Aca IS; Irmão JI; Morais MA; Coimbra MR; Carvalho LB
    Am J Trop Med Hyg; 2004 Feb; 70(2):221-4. PubMed ID: 14993636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA probe specific to pathogenic Entamoeba histolytica.
    Cruz-Reyes JA; Ackers JP
    Arch Med Res; 1992; 23(2):271-5. PubMed ID: 1340313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic methods for differentiation of Entamoeba histolytica and Entamoeba dispar in carriers: performance and clinical implications in a non-endemic setting.
    Visser LG; Verweij JJ; Van Esbroeck M; Edeling WM; Clerinx J; Polderman AM
    Int J Med Microbiol; 2006 Oct; 296(6):397-403. PubMed ID: 16753339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of DNA probes in characterization of pathogenic and non-pathogenic E. histolytica.
    Gopalkrishna BK
    J Assoc Physicians India; 1999 Oct; 47(10):1033. PubMed ID: 10778707
    [No Abstract]   [Full Text] [Related]  

  • 10. Entamoeba moshkovskii and Entamoeba dispar-associated infections in pondicherry, India.
    Parija SC; Khairnar K
    J Health Popul Nutr; 2005 Sep; 23(3):292-5. PubMed ID: 16262027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR differentiation of Entamoeba histolytica and Entamoeba dispar from patients with amoeba infection initially diagnosed by microscopy.
    Lebbad M; Svärd SG
    Scand J Infect Dis; 2005; 37(9):680-5. PubMed ID: 16126570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Entamoeba histolytica and Entamoeba dispar by PCR assay of fecal specimens obtained from Thai/Myanmar border region.
    Intarapuk A; Kalambaheti T; Thammapalerd N; Mahannop P; Kaewsatien P; Bhumiratana A; Nityasuddhi D
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):425-34. PubMed ID: 19842426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entamoeba histolytica and/or Entamoeba dispar: infection frequency in HIV+/AIDS patients in Mexico city.
    Moran P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C
    Exp Parasitol; 2005 Jul; 110(3):331-4. PubMed ID: 15955334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hybridization probe for clinical diagnosis of Entamoeba histolytica.
    Samuelson J; Acuna-Soto R; Reed S; Biagi F; Wirth D
    J Clin Microbiol; 1989 Apr; 27(4):671-6. PubMed ID: 2542361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entamoeba histolytica and Entamoeba dispar: comparison of two PCR assays for diagnosis in a non-endemic setting.
    Calderaro A; Gorrini C; Bommezzadri S; Piccolo G; Dettori G; Chezzi C
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):450-7. PubMed ID: 16274714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entamoeba histolytica and Entamoeba dispar: prevalence infection in a rural Mexican community.
    Ramos F; Morán P; González E; García G; Ramiro M; Gómez A; de León Mdel C; Melendro EI; Valadez A; Ximénez C
    Exp Parasitol; 2005 Jul; 110(3):327-30. PubMed ID: 15955333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entamoeba histolytica: an explanation for the reported conversion of "nonpathogenic" amebae to the "pathogenic" form.
    Clark CG; Diamond LS
    Exp Parasitol; 1993 Dec; 77(4):456-60. PubMed ID: 8253159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative method for DNA extraction and PCR identification of Entamoeba histolytica and E. dispar in fecal samples.
    Vianna EN; Costa JO; Santos CK; Cury MC; Silva EF; Costa AO; Gomes MA
    Parasitology; 2009 Jun; 136(7):765-9. PubMed ID: 19486545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for infection by the Entamoeba histolytica/E. dispar complex: an epidemiological study conducted in outpatient clinics in the city of Manaus, Amazon Region, Brazil.
    Benetton ML; Gonçalves AV; Meneghini ME; Silva EF; Carneiro M
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):532-40. PubMed ID: 15869773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [History of the Entamoeba histolytica protozoan].
    Pinilla AE; López MC; Viasus DF
    Rev Med Chil; 2008 Jan; 136(1):118-24. PubMed ID: 18483662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.